These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5637 related articles for article (PubMed ID: 4062258)

  • 21. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
    Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
    Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
    Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
    Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.
    Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S
    Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pectic polysaccharide isolated from Angelica gigas Nakai inhibits melanoma cell metastasis and growth by directly preventing cell adhesion and activating host immune functions.
    Han SB; Lee CW; Kang MR; Yoon YD; Kang JS; Lee KH; Yoon WK; Lee K; Park SK; Kim HM
    Cancer Lett; 2006 Nov; 243(2):264-73. PubMed ID: 16412568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of biological response modifier sulfoethylated (1 --> 3)-beta-D-glycan on the experimental leukemia in mice].
    Khalikova TA; Korolenko TA
    Eksp Klin Farmakol; 2006; 69(5):39-43. PubMed ID: 17153965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma.
    Sinai Y; Leibovici J; Wolman M
    Cancer Res; 1976 May; 36(5):1593-7. PubMed ID: 1268821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
    Zheng LM; Li Z; Liu L; Song BL; King I
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRD-glucan exhibits potent immunochemotherapeutic activity in vitro and in vivo.
    Moon SH; Heo JC; Fine RL; Kim HM; Kim SU; Yoon BD; Lee SH
    Int J Oncol; 2005 Feb; 26(2):395-404. PubMed ID: 15645124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
    Pierson HF; Meadows GG
    Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
    Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
    Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of macrophages and polymorphs in the levan-induced inhibition of Lewis lung carcinoma in C57BL mice.
    Leibovici J; Borit A; Sandbank U; Wolman M
    Br J Cancer; 1979 Oct; 40(4):597-607. PubMed ID: 497110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Captopril augments antitumor activity of cyclophosphamide in mice.
    Kowalski J; Herman ZS
    Pol J Pharmacol; 1996; 48(3):281-5. PubMed ID: 9112663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment of Lewis lung carcinoma by tumor excision and levan.
    Leibovici J; Michowitz M; Shezen E; Wolman M; Sandbank U
    Oncology; 1981; 38(1):31-4. PubMed ID: 7443174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of a novel polysaccharide preparation (GLPP) from Anhui-grown Ganoderma lucidum in tumor treatment and immunostimulation.
    Pang X; Chen Z; Gao X; Liu W; Slavin M; Yao W; Yu LL
    J Food Sci; 2007 Aug; 72(6):S435-42. PubMed ID: 17995702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
    Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
    Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
    Li LH; Johnson MA; Moeller RB; Wallace TL
    Cancer Res; 1984 Jul; 44(7):2841-7. PubMed ID: 6722813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 282.